• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病控制与并发症试验对非胰岛素依赖型糖尿病患者的意义。

Implications of the diabetes control and complications trial for persons with non-insulin-dependent diabetes mellitus.

作者信息

Vinik A I, Richardson D W

机构信息

Department of Internal Medicine, Eastern Virginia Medical School, Norfolk 23510, USA.

出版信息

South Med J. 1997 Mar;90(3):268-82. doi: 10.1097/00007611-199703000-00001.

DOI:10.1097/00007611-199703000-00001
PMID:9076296
Abstract

The Diabetes Control and Complications Trial has conclusively established that intensive control of insulin-dependent diabetes mellitus in persons aged 19 to 26 years (almost exclusively white, normotensive, nondyslipidemic, of normal weight, and insulin sensitive) reduces by +/- 50% the likelihood of retinopathy, nephropathy, and neuropathy. In contrast, persons with non-insulin-dependent diabetes mellitus (NIDDM) are older, overweight, hypertensive, dyslipidemic, and insulin resistant. Glycemia is only one of their risk factors, and they die of macrovascular disease. Review of studies supporting glycemic control versus risk factor reduction as management of NIDDM suggests a clear need to address risk factors besides glycemic control for successful prevention of complications of NIDDM. A new schematic proposal for intervention based upon risk factor reduction is presented.

摘要

糖尿病控制与并发症试验已确凿地证实,对19至26岁的胰岛素依赖型糖尿病患者(几乎全为白人,血压正常、血脂正常、体重正常且胰岛素敏感)进行强化控制,可使视网膜病变、肾病和神经病变的发生几率降低约50%。相比之下,非胰岛素依赖型糖尿病(NIDDM)患者年龄较大、超重、高血压、血脂异常且胰岛素抵抗。血糖只是他们的风险因素之一,他们死于大血管疾病。对支持将血糖控制与降低风险因素作为NIDDM管理方法的研究进行综述表明,除血糖控制外,明确需要解决其他风险因素,以成功预防NIDDM的并发症。本文提出了一项基于降低风险因素的新干预方案示意图。

相似文献

1
Implications of the diabetes control and complications trial for persons with non-insulin-dependent diabetes mellitus.糖尿病控制与并发症试验对非胰岛素依赖型糖尿病患者的意义。
South Med J. 1997 Mar;90(3):268-82. doi: 10.1097/00007611-199703000-00001.
2
Clinical review 51: Implications of the Diabetes Control and Complications Trial.临床综述51:糖尿病控制与并发症试验的启示
J Clin Endocrinol Metab. 1993 Nov;77(5):1105-7. doi: 10.1210/jcem.77.5.8077299.
3
Diabetes control and complications.糖尿病控制与并发症
Annu Rev Med. 1995;46:267-79. doi: 10.1146/annurev.med.46.1.267.
4
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.强化胰岛素治疗可预防日本非胰岛素依赖型糖尿病患者糖尿病微血管并发症的进展:一项随机前瞻性6年研究。
Diabetes Res Clin Pract. 1995 May;28(2):103-17. doi: 10.1016/0168-8227(95)01064-k.
5
Implications of the Diabetes Control and Complications Trial. American Diabetes Association.糖尿病控制与并发症试验的意义。美国糖尿病协会。
Diabetes. 1993 Nov;42(11):1555-8. doi: 10.2337/diab.42.11.1555.
6
Prevention and early detection of vascular complications of diabetes.糖尿病血管并发症的预防与早期检测
BMJ. 2006 Sep 2;333(7566):475-80. doi: 10.1136/bmj.38922.650521.80.
7
Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.研讨会八——视网膜病变、肾病、神经病变与严格控制
Am J Med. 1991 Feb 21;90(2A):80S-84S. doi: 10.1016/0002-9343(91)90045-y.
8
Lessons from the Diabetes Control and Complications Trial.糖尿病控制与并发症试验的经验教训。
Diabetes. 1993 Nov;42(11):1549-54. doi: 10.2337/diab.42.11.1549.
9
Insulin-dependent diabetes mellitus: pathophysiology.胰岛素依赖型糖尿病:病理生理学
Mayo Clin Proc. 1986 Oct;61(10):787-91. doi: 10.1016/s0025-6196(12)64818-6.
10
DCCT: implications for diabetes care in the UK.糖尿病控制与并发症试验:对英国糖尿病护理的启示
Diabet Med. 1993 Oct;10(8):687. doi: 10.1111/j.1464-5491.1993.tb00148.x.

引用本文的文献

1
Aldose Reductase and Protein Glycation Inhibitory Activity of Dark Chocolate-Assisted Zinc Oxide Nanoparticles.黑巧克力辅助氧化锌纳米颗粒的醛糖还原酶及蛋白质糖基化抑制活性
Cureus. 2023 Nov 17;15(11):e48953. doi: 10.7759/cureus.48953. eCollection 2023 Nov.
2
BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.BetaMe:一项综合数字健康计划对糖尿病和糖尿病前期患者12个月时糖化血红蛋白和体重的影响:一项随机对照试验的研究方案
Trials. 2018 Mar 5;19(1):161. doi: 10.1186/s13063-018-2528-4.